The 10-day moving average for CNO crossed bullishly above the 50-day moving average on October 26, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 10 of 15 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 67%.
The Momentum Indicator moved above the 0 level on October 13, 2026. You may want to consider a long position or call options on CNO as a result. In 56 of 86 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 65%.
The Moving Average Convergence Divergence (MACD) for CNO just turned positive on October 15, 2026. Looking at past instances where CNO's MACD turned positive, the stock continued to rise in 28 of 47 cases over the following month. The odds of a continued upward trend are 60%.
CNO moved above its 50-day moving average on October 27, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +6.02% 3-day Advance, the price is estimated to grow further. Considering data from situations where CNO advanced for three days, in 207 of 329 cases, the price rose further within the following month. The odds of a continued upward trend are 63%.
The Aroon Indicator entered an Uptrend today. In 184 of 296 cases where CNO Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 62%.
The RSI Indicator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
CNO broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Tickeron Profit vs. Risk Rating rating for this company is 3 (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock better than average.
The Tickeron PE Growth Rating for this company is 15 (best 1 - 100 worst), pointing to outstanding earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Price Growth Rating for this company is 39 (best 1 - 100 worst), indicating steady price growth. CNO’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Valuation Rating of 63 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (2.088) is normal, around the industry mean (1.339). P/E Ratio (19.760) is within average values for comparable stocks, (19.974). Projected Growth (PEG Ratio) (0.210) is also within normal values, averaging (0.463). Dividend Yield (0.012) settles around the average of (0.047) among similar stocks. P/S Ratio (1.156) is also within normal values, averaging (1.303).
The Tickeron SMR rating for this company is 94 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The RSI Oscillator for PUK moved out of oversold territory on October 15, 2026. This could be a sign that the stock is shifting from a downward trend to an upward trend. Traders may want to buy the stock or call options. The A.I.dvisor looked at 31 similar instances when the indicator left oversold territory. In 26 of the 31 cases the stock moved higher. This puts the odds of a move higher at 84%.
The Momentum Indicator moved above the 0 level on October 27, 2026. You may want to consider a long position or call options on PUK as a result. In 46 of 79 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are 58%.
The Moving Average Convergence Divergence (MACD) for PUK just turned positive on October 15, 2026. Looking at past instances where PUK's MACD turned positive, the stock continued to rise in 26 of 47 cases over the following month. The odds of a continued upward trend are 55%.
Following a +2.71% 3-day Advance, the price is estimated to grow further. Considering data from situations where PUK advanced for three days, in 165 of 281 cases, the price rose further within the following month. The odds of a continued upward trend are 59%.
The Stochastic Oscillator has been in the overbought zone for 1 day. Expect a price pull-back in the near future.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where PUK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 72%.
PUK broke above its upper Bollinger Band on October 30, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Aroon Indicator for PUK entered a downward trend on October 16, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Valuation Rating of 50 (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.560) is normal, around the industry mean (1.339). P/E Ratio (8.765) is within average values for comparable stocks, (19.974). PUK's Projected Growth (PEG Ratio) (2.391) is very high in comparison to the industry average of (0.463). Dividend Yield (0.027) settles around the average of (0.047) among similar stocks. P/S Ratio (1.124) is also within normal values, averaging (1.303).
The Tickeron Price Growth Rating for this company is 70 (best 1 - 100 worst), indicating slightly worse than average price growth. PUK’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 72 (best 1 - 100 worst), pointing to slightly better than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 92 (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. PUK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 60, placing this stock worse than average.
CNO | PUK | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 46 | 35 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 63 Fair valued | 50 Fair valued | |
PROFIT vs RISK RATING 1..100 | 3 | 100 | |
SMR RATING 1..100 | 94 | 92 | |
PRICE GROWTH RATING 1..100 | 39 | 70 | |
P/E GROWTH RATING 1..100 | 15 | 72 | |
SEASONALITY SCORE 1..100 | n/a | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
PUK's Valuation (50) in the Multi Line Insurance industry is in the same range as CNO (63) in the Life Or Health Insurance industry. This means that PUK’s stock grew similarly to CNO’s over the last 12 months.
CNO's Profit vs Risk Rating (3) in the Life Or Health Insurance industry is significantly better than the same rating for PUK (100) in the Multi Line Insurance industry. This means that CNO’s stock grew significantly faster than PUK’s over the last 12 months.
PUK's SMR Rating (92) in the Multi Line Insurance industry is in the same range as CNO (94) in the Life Or Health Insurance industry. This means that PUK’s stock grew similarly to CNO’s over the last 12 months.
CNO's Price Growth Rating (39) in the Life Or Health Insurance industry is in the same range as PUK (70) in the Multi Line Insurance industry. This means that CNO’s stock grew similarly to PUK’s over the last 12 months.
CNO's P/E Growth Rating (15) in the Life Or Health Insurance industry is somewhat better than the same rating for PUK (72) in the Multi Line Insurance industry. This means that CNO’s stock grew somewhat faster than PUK’s over the last 12 months.
| CNO | PUK | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 63% | 2 days ago 84% |
| Stochastic ODDS (%) | 2 days ago 59% | 2 days ago 66% |
| Momentum ODDS (%) | 2 days ago 65% | 2 days ago 58% |
| MACD ODDS (%) | 2 days ago 60% | 2 days ago 55% |
| TrendWeek ODDS (%) | 2 days ago 61% | 2 days ago 60% |
| TrendMonth ODDS (%) | 2 days ago 61% | 2 days ago 60% |
| Advances ODDS (%) | 2 days ago 63% | 2 days ago 59% |
| Declines ODDS (%) | N/A | 12 days ago 72% |
| BollingerBands ODDS (%) | 2 days ago 62% | 2 days ago 60% |
| Aroon ODDS (%) | 2 days ago 62% | 2 days ago 69% |
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
CNO’s FA Score shows that 2 FA rating(s) are green while PUK’s FA Score has 0 green FA rating(s).
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
CNO’s TA Score shows that 6 TA indicator(s) are bullish while PUK’s TA Score has 4 bullish TA indicator(s).
CNO (@Life/Health Insurance) experienced а +7.92% price change this week, while PUK (@Life/Health Insurance) price change was +4.99% for the same time period.
The average weekly price growth across all stocks in the @Life/Health Insurance industry was +1.29%. For the same industry, the average monthly price growth was -0.07%, and the average quarterly price growth was -2.76%.
CNO is expected to report earnings on Feb 09, 2027.
Life insurance companies mainly sell policies that pay a death benefit as a lump sum upon the death of the insured to their beneficiaries. Life insurance policies may be sold as term life, (which guarantees payment of a stated death benefit and expires at the end of a specified term) or permanent /typically whole life (which is more expensive but lasts a lifetime and carries a cash accumulation component). Life insurance firms may also sell long-term disability policies that help to replace the insured individual’s income if they become sick or disabled. Health insurance, on the other hand, helps pay for medical expenses. Anthem, Inc., MetLife, Inc. and Aflac Incorporated are some of the largest U.S. companies in this industry.
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| FEZ | 65.39 | 0.36 | +0.55% |
| State Street SPDR EURO STOXX 50 ETF (FEZ) | |||
| QBKV | 26.96 | N/A | +0.01% |
| AllianzIM U.S. Small Cap Buffer5 ETF (QBKV) | |||
| STOT | 46.34 | -0.16 | -0.34% |
| State Street DoubleLine Short Duration Total Return Tactical ETF (STOT) | |||
| NUSB | 25.15 | -0.09 | -0.36% |
| Nuveen Ultra Short Income ETF (NUSB) | |||
| XLYI | 21.95 | -0.22 | -0.97% |
| State Street Consumer Discretionary Select Sector SPDR Premium Income ETF (XLYI) | |||